"Enhancing Cancer Therapy: Israeli Institute Discovers Immune Cell Collaboration"

Researchers at the Weizmann Institute of Science have developed a new immunotherapy treatment that connects T cells to dendritic cells, resulting in a powerful immune response against cancerous growths. The treatment was found to be effective in reducing the growth rate of aggressive breast, lung, and skin cancers in mouse models. The new antibody, called BiCE, has shown promise in preventing the development of metastases in the lungs after the removal of the primary tumor. The institute has filed a patent application and is working on commercializing the innovative treatment, which could also have implications for autoimmune diseases.